CSat Investment Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
CSat Investment Advisory's LLY Position: Q1 2021 in Review
CSat Investment Advisory reduced its Eli Lilly (LLY) stake by 3.8% in Q1 2021, selling an estimated $196 and leaving 25 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #493.
CSat Investment Advisory first reported a position in LLY in Q2 2018 and has held it in 12 quarters since. The position peaked at $741K in Q3 2020. 1,949 funds tracked by Wall St. Rank hold LLY as of Q1 2021.
- CSat Investment Advisory held 25 shares of Eli Lilly worth $5K as of Q1 2021.
- CSat Investment Advisory sold 1 Eli Lilly share in Q1 2021, an estimated $196.
- Eli Lilly made up ﹤0.01% of CSat Investment Advisory's portfolio in Q1 2021, its #493 holding.
- CSat Investment Advisory first reported a position in Eli Lilly in Q2 2018 and has held it in 12 quarters since.
- CSat Investment Advisory's Eli Lilly position peaked at $741K in Q3 2020.
- 1,949 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2021.
Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.